[
    [
        {
            "time": "2018-12-19",
            "original_text": "Tilray shares surge after announcing $100 million deal with AB InBev to study cannabis-based beverages",
            "features": {
                "keywords": [
                    "Tilray",
                    "shares",
                    "surge",
                    "deal",
                    "AB InBev",
                    "cannabis-based beverages"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "beverages"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Tilray Stock Up on Medical Cannabis Collaboration With Sandoz",
            "features": {
                "keywords": [
                    "Tilray",
                    "Stock",
                    "Up",
                    "Medical",
                    "Cannabis",
                    "Sandoz"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Aduro Stock Surges on STING Activator Deal With Eli Lilly",
            "features": {
                "keywords": [
                    "Aduro",
                    "Stock",
                    "Surges",
                    "STING",
                    "Activator",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Glaxo, Pfizer to Merge Consumer Health Units, Form New JV",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Pfizer",
                    "Merge",
                    "Consumer",
                    "Health",
                    "Units",
                    "JV"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Pre-Market Most Active for Dec 19, 2018: GE, MU, RCII, GSK, PBR, NVS, AMD, QQQ, ABX, MFG, FB, SQQQ",
            "features": {
                "keywords": [
                    "Pre-Market",
                    "Most Active",
                    "GE",
                    "MU",
                    "RCII",
                    "GSK",
                    "PBR",
                    "NVS",
                    "AMD",
                    "QQQ",
                    "ABX",
                    "MFG",
                    "FB",
                    "SQQQ"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "industrials",
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Novartis, China's Gan & Lee push into insulin amid diabetes epidemic",
            "features": {
                "keywords": [
                    "Novartis",
                    "China",
                    "Gan & Lee",
                    "insulin",
                    "diabetes",
                    "epidemic"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Novartis links with China's Gan & Lee in global insulin push",
            "features": {
                "keywords": [
                    "Novartis",
                    "China",
                    "Gan & Lee",
                    "global",
                    "insulin"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Sandoz Enters Agreement To Commercialize Three Biosimilar Insulins - Quick Facts",
            "features": {
                "keywords": [
                    "Sandoz",
                    "Agreement",
                    "Commercialize",
                    "Biosimilar",
                    "Insulins"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-12-19",
            "original_text": "Alcon Acquires Privately-held Tear Film Innovations - Quick Facts",
            "features": {
                "keywords": [
                    "Alcon",
                    "Acquires",
                    "Privately-held",
                    "Tear",
                    "Film",
                    "Innovations"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "ophthalmology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]